FDA-Inspected Site

Terumo Cardiovascular Systems Corporation

14 FDA inspections are on record for Terumo Cardiovascular Systems Corporation in Ann Arbor, United States.

Clean· No action indicated

Ann Arbor, United States · Last updated July 10, 2026

Overview

  • 14 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2021-07-14.

At a glance

Inspections

14

Form 483s

4

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Jul 2021 – 14 Jul 2021Medical Devices & Rad HealthClean
2 Oct 2019 – 11 Oct 2019Medical Devices & Rad HealthClean
20 Sep 2017 – 3 Oct 2017Medical Devices & Rad HealthClean
1 Dec 2016 – 7 Dec 2016Medical Devices & Rad HealthClean
4 May 2016 – 13 May 2016Medical Devices & Rad HealthClean
22 Jan 2015 – 30 Jan 2015Medical Devices & Rad HealthClean
13 Jan 2014 – 17 Feb 2014Medical Devices & Rad Health483View 483 →
15 Jul 2013 – 19 Jul 2013Medical Devices & Rad HealthClean
28 Sep 2012Not recorded483On file
29 Mar 2010Not recorded483View 483 →
11 Aug 2008Not recorded483On file
9 Dec 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

17 Feb 2014
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Sargum C Sood, Thomas A Peter, Kimberly Lewandowski-Walker

17 Feb 2014
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Sargum C Sood, Thomas A Peter, Kimberly Lewandowski-Walker

17 Feb 2014
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Sargum C Sood, Thomas A Peter, Kimberly Lewandowski-Walker

17 Feb 2014
21 CFR 820.198(e)

Records of complaint investigation

Cited by Sargum C Sood, Thomas A Peter, Kimberly Lewandowski-Walker

29 Mar 2010
21 CFR 803.50(a)(1)

Report of Death or Serious Injury

Cited by Kimberly Lewandowski-Walker, Gary D Urbiel Goldner, Charles M Spyr, Ryan J Benedict

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.75(a)Cited across public-safe Form 483 observations2x
21 CFR 803.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 803.52(b)(5)Cited across public-safe Form 483 observations1x
21 CFR 803.56Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(e)Cited across public-safe Form 483 observations1x
21 CFR 820.20Cited across public-safe Form 483 observations1x
21 CFR 820.20(e)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x
21 CFR 820.90(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Terumo Cardiovascular Systems Corporation's 4 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat